Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$191.17 - $325.63 $173,773 - $295,997
-909 Reduced 1.19%
75,169 $24.5 Million
Q4 2023

Mar 05, 2024

BUY
$160.99 - $215.69 $36,866 - $49,393
229 Added 0.3%
76,078 $14.5 Million
Q4 2023

Feb 06, 2024

BUY
$160.99 - $215.69 $30,266 - $40,549
188 Added 0.25%
75,849 $14.5 Million
Q3 2023

Nov 13, 2023

BUY
$194.33 - $283.97 $11,076 - $16,186
57 Added 0.08%
75,661 $15.1 Million
Q2 2023

Dec 12, 2023

SELL
$223.05 - $302.68 $12,713 - $17,252
-57 Reduced 0.08%
75,604 $21.6 Million
Q2 2023

Aug 08, 2023

SELL
$223.05 - $302.68 $772,422 - $1.05 Million
-3,463 Reduced 4.38%
75,604 $21.6 Million
Q1 2023

Dec 12, 2023

BUY
$175.41 - $217.92 $541,490 - $672,719
3,087 Added 4.08%
78,748 $17.1 Million
Q1 2023

May 01, 2023

SELL
$175.41 - $217.92 $78,759 - $97,846
-449 Reduced 0.56%
79,067 $17.1 Million
Q4 2022

Feb 03, 2023

SELL
$204.38 - $296.82 $6.2 Million - $9 Million
-30,314 Reduced 27.6%
79,516 $16.3 Million
Q3 2022

Nov 08, 2022

SELL
$195.21 - $310.53 $1.83 Million - $2.91 Million
-9,370 Reduced 7.86%
109,830 $30.5 Million
Q2 2022

Aug 09, 2022

SELL
$115.91 - $214.48 $354,684 - $656,308
-3,060 Reduced 2.5%
119,200 $22.8 Million
Q1 2022

May 05, 2022

BUY
$127.96 - $207.36 $200,897 - $325,555
1,570 Added 1.3%
122,260 $25.4 Million
Q4 2021

Feb 02, 2022

BUY
$165.13 - $241.83 $952,965 - $1.4 Million
5,771 Added 5.02%
120,690 $21.5 Million
Q3 2021

Oct 26, 2021

BUY
$163.99 - $235.57 $4.9 Million - $7.04 Million
29,869 Added 35.12%
114,919 $23.7 Million
Q2 2021

Jul 27, 2021

BUY
$131.45 - $201.49 $3.88 Million - $5.94 Million
29,490 Added 53.08%
85,050 $16.1 Million
Q1 2021

Apr 27, 2021

BUY
$92.73 - $142.05 $5.15 Million - $7.89 Million
55,560 New
55,560 $7.24 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.